ELAM Luciferase Reporter Lentivirus

The ELAM luciferase reporter lentivirus is a powerful research tool consisting of lentiviral particles carrying a firefly luciferase reporter gene under the control of the human ELAM/ELAM1/E-selectin promoter. This lentiviral vector system offers several key advantages for gene delivery and expression studies. First, lentiviruses efficiently transduce both dividing and non-dividing cells, including primary cells and difficult-to-transfect cell types, enabling efficient gene delivery in a variety of experimental systems. Second, the integration of the reporter construct into the host genome allows for stable, long-term expression of the luciferase reporter gene, facilitating long-term studies. Third, the viral particles are pseudotyped with the VSV-G envelope protein, enabling infection of a wide range of mammalian cell types. Furthermore, the system exhibits high transduction efficiency while maintaining low cytotoxicity, making it ideal for sensitive cellular assays.

This ELAM-driven luciferase reporter lentivirus has broad applications in biomedical research. Because the ELAM promoter is selectively induced under these conditions, it is an excellent tool for studying inflammatory responses, endothelial cell activation, and leukocyte-endothelial cell interactions. Researchers can utilize this system to monitor the NF-κB signaling pathway and other inflammatory cascades that regulate E-selectin expression. The luciferase reporter gene allows for quantitative measurement of promoter activity via sensitive luminescence detection, enabling high-throughput screening of compounds that modulate inflammation. This system is particularly valuable for drug discovery targeting inflammatory diseases, atherosclerosis, or cancer metastasis, as endothelial cell activation plays a crucial role in these diseases. Additionally, the lentiviral delivery method allows for the establishment of stable reporter cell lines for long-term studies of inflammatory processes.